Study guide

1.2 Cardiovascular and Anticoagulant Medications

PTCE Pharmacy Technician Certification Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the PTCE How to Use This Guide

2 Chapter 1: Medications

1.1 Generic and Brand Drug Names & Classifications 1.2 Cardiovascular and Anticoagulant Medications 1.3 Anti-Infective and Analgesic Medications 1.4 Endocrine, Respiratory, CNS, and Storage Requirements

3 Chapter 2: Federal Requirements

2.1 DEA Regulations and Controlled Substance Schedules 2.2 Drug Supply Chain Security Act (DSCSA) 2.3 FDA Regulations and Drug Recalls 2.4 HIPAA, CMEA, and Prescription Requirements

4 Chapter 3: Patient Safety and Quality Assurance

3.1 Medication Error Prevention 3.2 High-Alert and Look-Alike/Sound-Alike Medications 3.3 Patient Counseling and Communication 3.4 Quality Assurance and Continuous Quality Improvement

5 Chapter 4: Order Entry and Processing

4.1 Prescription Interpretation 4.2 Pharmacy Calculations 4.3 Inventory Management and NDC Numbers 4.4 Insurance, Billing, and Prescription Processing

1.2 Cardiovascular and Anticoagulant Medications

Key Takeaways Explain This Topic AI

Cardiovascular medications include antihypertensives, antiarrhythmics, antianginals, and lipid-lowering agents.

Warfarin requires INR monitoring; common target is 2.0-3.0 for most conditions.

DOACs (Direct Oral Anticoagulants) like rivaroxaban and apixaban have fewer drug interactions than warfarin.

Sublingual nitroglycerin stays in its original glass container, tightly capped after each use, to prevent loss of potency; tablets work within 1-3 minutes.

Many cardiovascular drugs require dose adjustments for renal impairment.

Last updated: October 2026

Cardiovascular disease is the leading cause of death in the United States, making cardiovascular medications among the most frequently dispensed. Pharmacy technicians must understand these medications thoroughly.

Antihypertensive Medications

These drugs lower blood pressure and reduce the risk of heart attack, stroke, and kidney disease.

ACE Inhibitors (-pril)

  • Generic Name Brand Name Common Strengths Key Points
  • lisinopril Zestril, Prinivil 2.5, 5, 10, 20, 40 mg Most prescribed ACE inhibitor
  • enalapril Vasotec 2.5, 5, 10, 20 mg Available IV as enalaprilat
  • benazepril Lotensin 5, 10, 20, 40 mg Often combined with amlodipine
  • ramipril Altace 1.25, 2.5, 5, 10 mg Indicated post-MI
  • Side Effects: Dry cough (up to 20% of patients), hyperkalemia, angioedema (rare but serious)
  • Contraindications: Pregnancy (can cause fetal harm), history of angioedema
  • ARBs (Angiotensin Receptor Blockers) (-sartan)
  • Generic Name Brand Name Common Strengths Key Points
  • losartan Cozaar 25, 50, 100 mg First ARB approved
  • valsartan Diovan 40, 80, 160, 320 mg Also for heart failure
  • olmesartan Benicar 5, 20, 40 mg High potency
  • irbesartan Avapro 75, 150, 300 mg Diabetic nephropathy
  • Advantage: Less likely to cause cough than ACE inhibitors; used when ACE inhibitors aren't tolerated
  • Beta Blockers (-olol)
  • Generic Name Brand Name Common Strengths Selectivity
  • metoprolol tartrate Lopressor 25, 50, 100 mg Cardioselective (beta-1)
  • metoprolol succinate Toprol-XL 25, 50, 100, 200 mg Extended release
  • atenolol Tenormin 25, 50, 100 mg Cardioselective
  • carvedilol Coreg 3.125, 6.25, 12.5, 25 mg Non-selective + alpha blocker
  • propranolol Inderal 10, 20, 40, 60, 80 mg Non-selective
  • Side Effects: Bradycardia, fatigue, cold extremities, may mask hypoglycemia symptoms
  • Warning: Should not be stopped abruptly - may cause rebound hypertension
  • Calcium Channel Blockers
  • Generic Name Brand Name Type Key Points
  • amlodipine Norvasc Dihydropyridine Most prescribed CCB
  • nifedipine ER Procardia XL Dihydropyridine Must not be crushed
  • diltiazem Cardizem, Dilacor Non-dihydropyridine Also for arrhythmias
  • verapamil Calan, Verelan Non-dihydropyridine Strongest negative inotrope
  • Side Effects (Dihydropyridines): Peripheral edema, headache, flushing, reflex tachycardia
  • Lipid-Lowering Agents
  • Statins (HMG-CoA Reductase Inhibitors)
  • Generic Name Brand Name Relative Potency Metabolism
  • atorvastatin Lipitor High CYP3A4
  • rosuvastatin Crestor Highest Minimal CYP
  • simvastatin Zocor Moderate CYP3A4
  • pravastatin Pravachol Lower Not CYP dependent
  • lovastatin Mevacor Moderate CYP3A4, take with food
  • Side Effects: Myalgia (muscle pain), elevated liver enzymes, rare but serious rhabdomyolysis
  • Drug Interactions: Grapefruit juice increases levels of some statins (atorvastatin, simvastatin, lovastatin)
  • Anticoagulants

Anticoagulants prevent blood clots and are critical in preventing stroke and treating DVT/PE.

Warfarin (Coumadin)

  • Parameter Details
  • Mechanism Vitamin K antagonist
  • Monitoring INR (International Normalized Ratio)
  • Target INR 2.0-3.0 for most conditions; 2.5-3.5 for mechanical heart valves
  • Antidote Vitamin K (phytonadione), FFP, or PCC

Key Drug Interactions:

  • Increased bleeding risk: NSAIDs, aspirin, antibiotics, antifungals
  • Decreased effectiveness: Vitamin K (green leafy vegetables), rifampin
  • Counseling Points: Maintain consistent vitamin K intake; avoid significant dietary changes
  • Direct Oral Anticoagulants (DOACs)
  • Generic Name Brand Name Mechanism Key Points
  • rivaroxaban Xarelto Factor Xa inhibitor Take with food (15 mg, 20 mg doses)
  • apixaban Eliquis Factor Xa inhibitor Twice daily dosing
  • dabigatran Pradaxa Direct thrombin inhibitor Keep in original container
  • edoxaban Savaysa Factor Xa inhibitor Once daily

Advantages over Warfarin:

  • No routine monitoring required
  • Fewer drug and food interactions
  • Predictable pharmacokinetics
  • Rapid onset and offset
  • Antiplatelet Agents
  • Generic Name Brand Name Mechanism Common Use
  • aspirin Bayer, Ecotrin COX inhibitor MI prevention, stroke prevention
  • clopidogrel Plavix P2Y12 inhibitor Post-stent, ACS
  • prasugrel Effient P2Y12 inhibitor ACS with PCI
  • ticagrelor Brilinta P2Y12 inhibitor ACS, reversible binding
  • Important: Clopidogrel is a prodrug requiring CYP2C19 activation; avoid PPIs like omeprazole (interaction)
  • Antianginal Medications
  • Nitroglycerin
  • Formulation Onset Duration Storage Requirements
  • Sublingual tablet 1-3 min 30-60 min Original glass container, tightly capped after each use; 20-25°C
  • Translingual spray 2-5 min 30-60 min 3-year shelf life
  • Transdermal patch 30-60 min 12-14 hours Nitrate-free interval needed

Counseling Points:

  • SL tablets: Place under tongue, do not swallow; may take up to 3 doses (5 minutes apart)
  • Call 911 if chest pain not relieved after first dose
  • Headache is a common side effect (indicates drug is working)
  • Contraindication: Do NOT use with PDE-5 inhibitors (sildenafil, tadalafil) - severe hypotension risk